Mitsubishi Tanabe Pharma Corporation

Industry

  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
    • OTC, Consumer
    • Nutraceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products

Other Names/Subsidiaries

  • Benesis
  • BIXEN Corporation
  • Bipha
  • Choseido Pharmaceutical
  • Guangdong Tanabe Pharmaceutical
  • Medicago
  • Mitsubishi Tanabe Pharma America
  • Mitsubishi Tanabe Pharma Canada
  • Mitsubishi Tanabe Pharma Development (Beijing)
  • Mitsubishi Tanabe Pharma Europe
  • Mitsubishi Tanabe Pharma Singapore
  • Mitsubishi Tanabe Pharma
See more in Biomedtracker

Latest on Mitsubishi Tanabe Pharma Corporation

Scrip

GlycoEra’s Series B Cash Will Fund Efforts To Take On FcRn Inhibitor Class

 
• By Joseph Haas

US/Swiss biotech GlycoEra AG announced a $130m series B financing on 27 May that it says will enable it to advance its first protein-degradation drug candidate through Phase II proof of concept as pre

Scrip

Asia Deal Watch: Lilly Partners With Rznomics On Hearing Loss

 
• By Joseph Haas, Xu Hu, Anju Ghangurde, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On

In Vivo

Dealmaking Quarterly Statistics, Q1 2025

 
• By Deanna Kamienski and Maureen Riordan

Biopharma merger and acquisition value for the first quarter of 2025 reached $38.4bn from 41 transactions, 22 of which had disclosed values. Making up almost 38% of that total was Johnson & Johnso

Scrip

Asia Deal Watch: Dr. Reddy’s Gets Regional Rights To Pair Of Bio-Thera Biosimilars

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From